ID

27528

Beschrijving

Study part: Concomitant Medication Treatment Phase. An open-label, up-titration study to assess the dose proportionality of ropinirole controlled release (CR) and to demonstrate the bioequivalence of ropinirole CR (1 x 8 mg) compared to the ropinirole CR (4 x 2 mg) in Parkinson's Disease patients not receiving other dopaminergic therapies. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Phase: phase 2. Study Recruitment Status: Completed. Generic Name: ropinirole. Trade Name: Modutab, ZIPEREVE, ZEPREVE, REPREVE, ADARTREL, REQUIP,Zygara. Study Indication: Parkinson Disease. Study ID: 101468/165. Clinical Study ID: 101468/165

Trefwoorden

Versies (1)
  1. 19-11-17 19-11-17 -
Houder van rechten

GlaxoSmithKline

Geüploaded op

19 november 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Concomitant Medication Treatment Phase Ropinirole Parkinson Disease 101468/165

Engels

Concomitant Medication Treatment Phase

1 Formulieren  
CONCOMITANT MEDICATION
Beschrijving

CONCOMITANT MEDICATION

Alias
UMLS CUI-1
C2347852
Patient Number
Beschrijving

Patient Number

Datatype

integer

Alias
UMLS CUI [1]
C1830427
Are there any concomitant medication changes since the start of the study?
Beschrijving

Concomitant Medication

Datatype

boolean

Alias
UMLS CUI [1]
C2347852
Drug Name
Beschrijving

Drug Name

Datatype

text

Alias
UMLS CUI [1]
C0013227
Single dose/Unit
Beschrijving

Single dose

Datatype

text

Alias
UMLS CUI [1]
C1960417
Frequency of this dose
Beschrijving

dose frequency

Datatype

text

Alias
UMLS CUI [1]
C2826654
Route
Beschrijving

Route

Datatype

text

Alias
UMLS CUI [1]
C0013153
Indication
Beschrijving

Indication

Datatype

text

Alias
UMLS CUI [1]
C3146298
Start Date/Time
Beschrijving

Start Date and Time

Datatype

datetime

Alias
UMLS CUI [1]
C3897500
End Date/Time
Beschrijving

End Date and Time

Datatype

datetime

Alias
UMLS CUI [1]
C3899266
Terug naar het begin van de pagina

Similar models

Concomitant Medication Treatment Phase

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
CONCOMITANT MEDICATION
C2347852 (UMLS CUI-1)
Patient Number
Item
Patient Number
integer
C1830427 (UMLS CUI [1])
Concomitant Medication
Item
Are there any concomitant medication changes since the start of the study?
boolean
C2347852 (UMLS CUI [1])
Drug Name
Item
Drug Name
text
C0013227 (UMLS CUI [1])
Single dose
Item
Single dose/Unit
text
C1960417 (UMLS CUI [1])
dose frequency
Item
Frequency of this dose
text
C2826654 (UMLS CUI [1])
Route
Item
Route
text
C0013153 (UMLS CUI [1])
Indication
Item
Indication
text
C3146298 (UMLS CUI [1])
Start Date and Time
Item
Start Date/Time
datetime
C3897500 (UMLS CUI [1])
End Date and Time
Item
End Date/Time
datetime
C3899266 (UMLS CUI [1])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial